The molecular diagnostics market size is valued at USD 17.6 billion in 2025 and is projected to reach USD 36.2 billion by the end of 2035, with a compound annual growth rate (CAGR) of 7.4% during the ...

Osteoporosis has long been treated as a disease of bone tissue alone, a slow thinning of the skeleton driven by aging, estrogen loss, and an imbalance between the cells that build bone and the cells ...

Precision medicine, drug discovery and cell/gene therapies are driving adoption, creating opportunities in automation, spatial multi-omics, AI bioinformatics and clinical diagnostics.Dublin, Sept. 24, ...

In adult neuroendocrine malignancies, including small cell lung cancer, Delta-like ligand 3 (DLL3) is a validated therapeutic target. DLL3 is expressed in neuroblastoma, a pediatric cancer of ...

While heart transplantation (HT) is the optimal therapy for end-stage heart failure patients, longevity of HT recipients ...

This is a valuable study that contributes to our understanding of transcriptomic responses in microglia to HIV infection in the human brain. The evidence provided remains incomplete, and further ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.